Treatment of congenital adrenal hyperplasia in children aged 0–3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure

OBJECTIVES: International guidelines recommend additional salt supplementation during infancy in classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The influence of corticoid medication and growth has not been assessed. AIM: To investigate the current use of salt suppleme...

Descripción completa

Detalles Bibliográficos
Autores principales: Neumann, Uta, van der Linde, Annelieke, Krone, Ruth E, Krone, Nils P, Güven, Ayla, Güran, Tülay, Elsedfy, Heba, Poyrazoglu, Sukran, Darendeliler, Feyza, Bachega, Tania A S S, Balsamo, Antonio, Hannema, Sabine E, Birkebaek, Niels, Vieites, Ana, Thankamony, Ajay, Cools, Martine, Milenkovic, Tatjana, Bonfig, Walter, Costa, Eduardo Correa, Atapattu, Navoda, de Vries, Liat, Guaragna-Filho, Guilherme, Korbonits, Marta, Mohnike, Klaus, Bryce, Jillian, Ahmed, S Faisal, Voet, Bernard, Blankenstein, Oliver, Claahsen-van der Grinten, Hedi L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066592/
https://www.ncbi.nlm.nih.gov/pubmed/35290211
http://dx.doi.org/10.1530/EJE-21-1085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066592/
https://www.ncbi.nlm.nih.gov/pubmed/35290211
http://dx.doi.org/10.1530/EJE-21-1085

Ejemplares similares